Drug class
Papaverine-like smooth-muscle antispasmodic; phosphodiesterase IV inhibitor
Mechanism of action
Inhibits phosphodiesterase activity, increasing intracellular cAMP and reducing calcium-dependent smooth-muscle contraction. It acts directly on smooth muscle and does not function primarily as an antimuscarinic.
General use cases
- Symptomatic relief of smooth-muscle spasm and associated pain, including gastrointestinal, biliary, urinary and gynaecological spasm, in countries where drotaverine is authorised; indication and route are jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
